Unit 4 - Hyperlipidemia Flashcards
what are lipoproteins? materials?
spherical particles with hydrophilic monolayer surface made of phospholipid, protein, and cholesterol
- shields hydrophobic lipid core of TG and cholesterol esters
- apoliporoteins provide structural stability to prticle, are required for assembly/secretion, and act as ligands and cofactors
what are the three compartments of plasma lipoprotein metabolism?
- exogenous lipid transport
- endogenous lipid transport
- reverse cholesterol transport
explain exogenous lipid transport?
- chol and TG ingested and emulsified in intestines bybile acids
- combined with PRO to form chylomicrons in gut wall
- secrted into circulation, delivering TG to adipose and muscles via LPL in plasma or vscular endothelial cells
- remaining chol-rich remnants deliver cholesterol to liver
explain endogenous lipid transport
- liver forms VLDL from TG, chol, and PRO, and secretes into circulation
- VLDL deliver TG to adipose and fat, and are converted into IDL and LDL
- chol-rich LDL delivers to peripheral tissues for cell membranes, steroids
- -delivers to nascent atheromas to be oxidized and phagocytosed by MP –> foam cells
- -deliver to liver (apo-100 binds to LDL-R to promote internalization)
what does intracellular cholesterol do to the cell?
3 regulatory effects
- decreases activity of HMG CoA reductase (rate-limiting in chol synthesis)
- activates ACAT (acetyl CoA: cholesterol acyltransferase) that esterifies free chol into chol ester for storage
- inhibits transription of gene encoding LDL-R (decreases further uptake of chol by cell)
explain reverse cholesterol transport
nascent HDL particles with PRO and small amt of phospholipid are secreted by gut and liver
-as HDL circulate in blood, they use plasma LCAT to get chol from peripheral tissues and atheromas, to be transported to liver
explain the pathogenesis of atherosclerosis
- endothelial injury
- low-grade inflammatoryresponse causing LDL accumulation and oxidation
- blood monocytes adhere, becoming macrophages
- MP phagocytose ox-LDL to become foam cells
- platelets adhere
- SMC migration deposits collagen
- necrosis, plaque lysis
what are primary hyperlipidemic states?
relatively rare disorders, each of which is caused by monogenic defect
-LDL receptor deficiency
what are secondarycauses of hyperlipidemia?
- hypothyroidism
- early nephrosis
- resolving lipemia
- immunoglobulin-lipoprotein complex disorders
- anorexia nervosa
- cholestasis
- hypopituitarism
- corticosteroid excess
what is polygenic-environmental hyerlipidemia?
most cases, due to several genes that predispose patient to milder forms of hyperlipoproteinemia particularly in the presence of excessive dietary intake of lipids, or other risk factors
- serum LDL cholesterol
- age
- HTN
- smoking
what is the goal of the AHA step 1 diet?
for many, may be the only treatment necessary
- attain normal bodyweight and minimize plasma lipids
- cholesterol < 300 mg/day
- total fat < 30% of total calories
- saturated fat < 10% total calories
what increases/decreases HDL cholesterol concentrations?
- estrogens > androgens
- exercise > puberty (in males)
- leanness > obesity
- alcohol (in moderation) > cigarette smoking
- familial hyperalphaproteinemia > familial HDL deficiency
- antihyperlipidemic drugs > DM II or hypertriglyceridemia
when is drug therapy considered?
if diet and weight loss haven’t lowered total and LDL cholesterol to desired ranges (160/130) within 6-12 months, or for patients with moderate risk of CHD
what is niacin? what are its effects on lipids? when do you use them?
vitamin only after conversion to NAD, but require larger amounts to show hypolipidemic effects
- affects virtually all lipid parameters
- increase HDL 15-35% (best)
- lower TG by 20-50% (as effective as fibrates and statins)
- reduces LDL by 5-25%
- useful for patients with both hypertriglyceridemia andlow HDL levels, but has numerous and serious side effects
what is the mechanism of niacin?
- reduced TG synthesis in liver, reducing hepatic VLDL production (and thus LDL levels)
- decreased lipolysis in adipose tissue, reducing transport of FFA to liver (thus decreasing hepatic TG synthesis)
- reduced hepatic clearance of HDL-apo A-1 (thus raising HDL levels)